Project Grant R01CA292899
Award Date
5/2/25
Completion Date
4/30/28
Dollars Obligated
$516K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This National Institute on Minority Health and Health Disparities (NIMHD) Project Grant award under the Minority Health and Health Disparities Research (CFDA 93.307) program aims to evaluate population-based strategies for improving smoking cessation rates among rural populations. The $694,771 award to the Regents of the University of Minnesota will fund a randomized controlled trial to determine the efficacy of providing rural people who smoke with a free nicotine replacement therapy (NRT)...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the relative risks of tobacco products. The project aims to generate effective messaging on the continuum of tobacco product risks, assess their impact on message response, receptivity, and behavioral precursors,...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $622,957 to Duke University to conduct research on the chemical composition and behavioral effects of novel tobacco products. The key objectives are to: 1) Analyze the chemical composition of oral nicotine pouches and "non-menthol" cigarettes for flavors, sweeteners, and...
This Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will provide $773,359 to the University of Wisconsin-Madison to conduct a randomized controlled trial. The study will evaluate the effectiveness of nicotine pouches compared to FDA-approved nicotine mini-lozenges in helping adult daily smokers substitute cigarettes over a 4-week period. The research aims to assess product...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $188,913 to Virginia Commonwealth University (VCU) to conduct research on nicotine continuum of risk education for socioeconomically disadvantaged adult smokers. The key objectives are to: 1) assess perceptions of the continuum of risk among low-socioeconomic status (low-SES) smokers using...
This National Cancer Institute (NCI) research project grant under the Cancer Cause and Prevention Research program (CFDA 93.393) is designed to explore consumer responses to the FDA's new authorizations allowing certain smokeless tobacco products to make modified risk claims in their marketing. The $885,824 grant, awarded to Health Research, Inc. at Roswell Park in Buffalo, NY, will fund a series of complementary research activities over a 2-year period from August 2024 to July 2026. The key...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $625,201 to the University of Oklahoma Health Sciences Center Division to conduct a randomized factorial trial evaluating the combination of varenicline and nicotine lozenges, with and without a smartphone-based medication adherence intervention, to promote smoking cessation. The goal is to improve smoking cessation treatment and decrease cancer risk. The research will enroll...
This federal Project Grant award of $279,573, made by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, aims to refine and test a novel biobehavioral smoking cessation intervention. The intervention integrates the strategic application of olfactory stimuli to reduce cigarette cravings with an established smartphone-based smoking cessation application. The 3-year project, which commenced on September 11, 2024, will be conducted by the...
This $395,051 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to evaluate the implementation and short-term impact of a new statewide policy in New Jersey that requires tobacco retailers to sell nicotine replacement therapy (NRT). The key objectives are to: 1) determine if NRT compliance varies by neighborhood characteristics, and 2) explore trends in NRT product sales and quitline calls before and after the policy was...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will provide $371,822 to Rutgers, The State University of New Jersey, to conduct research on the impact of cigar package quantity on cigar use behaviors. The key objectives of this 5-year project are to: 1) characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data sources; and...